Antithrombotic Management for Transcatheter Aortic Valve Implantation.
Lina Ya'QoubJelena ArnautovicMusa SharkawiMirvat AlAasnagHani JneidAkram Y ElgendyPublished in: Journal of clinical medicine (2023)
In most patients without concomitant indication for oral anticoagulation, single antiplatelet therapy is recommended post TAVI.
Keyphrases
- transcatheter aortic valve implantation
- antiplatelet therapy
- aortic stenosis
- aortic valve
- ejection fraction
- aortic valve replacement
- end stage renal disease
- acute coronary syndrome
- atrial fibrillation
- percutaneous coronary intervention
- newly diagnosed
- chronic kidney disease
- transcatheter aortic valve replacement
- peritoneal dialysis
- venous thromboembolism
- prognostic factors
- coronary artery disease